Responses
Clinical/translational cancer immunotherapy
Original research
Myeloid-derived suppressor cells attenuate the antitumor efficacy of radiopharmaceutical therapy using 90Y-NM600 in combination with androgen deprivation therapy in murine prostate tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.
